Johnson & Johnson has agreed to buy biotechnology company Firefly Bio for $1 billion in cash in a deal that bolsters the drugmaker’s oncology pipeline.
Johnson & Johnson to Buy Firefly Bio for $1 Billion
Get alerts for these topics
GoKawiil
Tech News